Verrica Pharmaceuticals Announces Exclusive Licensing Agreement With Torii Pharmaceutical Co., Ltd. To Develop and Commercialize VP-102 For Molluscum and Common Warts in Japan

NEXT STORY
Codiak BioSciences Reports Fourth Quarter and Full Year 2020 Financial Results and Operational Progress
PREV STORY
Guidewire Market to Reach USD 1,401.0 Million at 5.9% CAGR; Growing Rate of Coronary Surgeries to Bolster Sales Opportunities: Fortune Business Insights™
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Galena Biopharma Announces Completion of Enrollment in Two NeuVax™ (nelipepimut-S) Clinical Trials in Combination with Trastuzumab

SAN RAMON, Calif., Sept. 28, 2017 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (NASDAQ:GALE), a ...

author_avatar
NASDAQ Market News

Zosano Announces Positive Data from a Nonclinical Evaluation of Pharmacokinetics and Skin Tolerability Study for ADAM™ Technology for the Delivery of Zolmitriptan

Peer-reviewed article published in Journal of Pharmaceutical Science evaluates skin tolerability and bioavailability of ...

author_avatar
NASDAQ Market News

Roche presents data from across its breast cancer portfolio at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting

author_avatar
NASDAQ Market News